FOLFIRI regimen as second-/third-line chemotherapy in patients with advanced pancreatic adenocarcinoma refractory to gemcitabine and platinum salts: A retrospective series of 70 patients.

被引：0
|
作者：
Neuzillet, C.
Hentic, O.
Rousseau, B.
Rebours, V.
Bengrine-Lefevre, L.
Bonnetain, F.
Raymond, E.
Ruszniewski, P.
Louvet, C.
Hammel, P.
机构：
[1] Hop Beaujon, Clichy La Garenne, France
[2] Hop St Antoine, F-75571 Paris, France
[3] Ctr Georges Francois Leclerc, Dijon, France
[4] Beaujon Univ Hosp, Clichy, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4132
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and Protracted 5-Fluorouracil Infusion as Third-line Chemotherapy in Refractory Colorectal Cancer Patients
    Bitossi, Raffaella
    Sculli, Carla Maria
    Tampellini, Marco
    Alabiso, Irene
    Brizzi, Maria Pia
    Ferrero, Anna
    Ottone, Azzurra
    Bellini, Elisa
    Gorzegno, Gabriella
    Berruti, Alfredo
    Dogliotti, Luigi
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3055 - 3060
  • [22] Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy
    Kim, Bomi
    Kim, Jaihwan
    Yang, Soomin
    Ahn, Jinwoo
    Jung, Kwangrok
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [23] Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
    Sperone, Paola
    Ferrero, Anna
    Daffara, Fulvia
    Priola, Adriano
    Zaggia, Barbara
    Volante, Marco
    Santini, Daniele
    Vincenzi, Bruno
    Badalamenti, Giuseppe
    Intrivici, Chiara
    Del Buono, Sabrina
    De Francia, Silvia
    Kalomirakis, Emmanouil
    Ratti, Riccardo
    Angeli, Alberto
    Dogliotti, Luigi
    Papotti, Mauro
    Terzolo, Massimo
    Berruti, Alfredo
    ENDOCRINE-RELATED CANCER, 2010, 17 (02) : 445 - 453
  • [24] Second-line chemotherapy by FOLFIRI in patients with advanced small bowel adenocarcinoma A multicenter AGEO study
    Zaanan, A.
    Gauthier, M.
    Malka, D.
    Locher, C.
    Gornet, J.
    Thirot-Bidault, A.
    Tougeron, D.
    Taieb, J.
    Bonnetain, F.
    Aparicio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Papadimitrakopoulou, Vassiliki A.
    Soria, Jean-Charles
    Jappe, Annette
    Jehl, Valentine
    Klimovsky, Judith
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1594 - 1601
  • [26] SECOND-LINE CHEMOTHERAPY WITH FLUOROURACIL, LEUCOVORIN, AND IRINOTECAN (FOLFIRI REGIMEN) IN PATIENTS WITH ADVANCED SMALL BOWEL ADENOCARCINOMA AFTER FAILURE OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY: A MULTICENTER AGEO STUDY
    Aparicio, T.
    Zaanan, A.
    Gauthier, M.
    Malka, D.
    Locher, C.
    Gornet, J.
    Thirot-Bidault, A.
    Tougeron, D.
    Taieb, J.
    Bonnetain, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
  • [27] Second-Line Chemotherapy With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI Regimen) in Patients With Advanced Small Bowel Adenocarcinoma After Failure of First-Line Platinum-Based Chemotherapy A Multicenter AGEO Study
    Zaanan, Aziz
    Gauthier, Melanie
    Malka, David
    Locher, Christophe
    Gornet, Jean-Marc
    Thirot-Bidault, Anne
    Tougeron, David
    Taieb, Julien
    Bonnetain, Franck
    Aparicio, Thomas
    CANCER, 2011, 117 (07) : 1422 - 1428
  • [28] A randomized second line trial in patients with gemcitabine refractory advanced pancreatic cancer - CONKO 003
    Riess, H.
    Pelzer, U.
    Stieler, J.
    Schwaner, I.
    Heil, G.
    Goerner, M.
    Moelle, M.
    Hilbig, A.
    Doerken, B.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] The efficacy and safety of nanoparticle albumin bound-paclitaxel-based regimen as second- or third-line treatment in patients with advanced esophageal squamous cell carcinoma
    Xin, Dao
    Song, Yan
    Mu, Lan
    Zhang, Bo
    Qi, Ling
    Gao, Jing
    Wang, Xingyuan
    Xu, Jianping
    Qu, Tao
    Huang, Jing
    THORACIC CANCER, 2023, 14 (15) : 1392 - 1397
  • [30] Standards of Care and Treatment Patterns Among Relapsed/Refractory Multiple Myeloma Patients Initiating Second- and Third-Line Therapies
    Boytsov, Natalie
    Gorsh, Boris
    Anderson, Seth
    Wang, Peter Feng
    Perera, Sue
    Franklin, Meg
    BLOOD, 2022, 140 : 12554 - 12555
12345